Suchergebnisse - "Ivy, S. Percy"

PubPharm (253)

1

Impact of the 2021 CKD-EPI equation on anticancer pharmacotherapy in black and non-black cancer patients

enthalten in: Cancer letters | 2024

von Butrovich, M. | Qin, J. | Xue, X. | +3

2

Circulating Tumor DNA Dynamics Fail to Predict Efficacy of Poly(ADP-ribose) Polymerase/VEGFR Inhibition in Patients With Heavily Pretreated Advanced Solid Tumors

enthalten in: JCO precision oncology | 2024

von Hu, Y. | Narayan, A. | Xu, Y. | +10

3

Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications : Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1

enthalten in: JCO precision oncology | 2024

von Gong, J. | Mita, A. | Wei, Z. | +19

4

Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions : Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2

enthalten in: JCO precision oncology | 2024

von Gong, J. | Mita, A. | Wei, Z. | +18

5

The New NCI Precision Medicine Trials

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Harris, L. | Blanke, C. | Erba, H. | +22

6

Enhancing quality and impact of early phase dose-finding clinical trial protocols : SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidance

enthalten in: BMJ (Clinical research ed.) | 2023

von Yap, C. | Rekowski, J. | Ursino, M. | +32

7

Enhancing reporting quality and impact of early phase dose-finding clinical trials : CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance

enthalten in: BMJ (Clinical research ed.) | 2023

von Yap, C. | Solovyeva, O. | de Bono, J. | +32

8

Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Ingham, M. | Allred, J. | Chen, L. | +19

ErratumIn: J Clin Oncol. 2023 Nov 20;41(33):5205. - PMID 37801676

9

A phase 1 study of veliparib (ABT-888) plus weekly carboplatin and paclitaxel in advanced solid malignancies, with an expansion cohort in triple negative breast cancer (TNBC) (ETCTN 8620)

enthalten in: Breast cancer research and treatment | 2023

von Malhotra, M. | Pahuja, S. | Kiesel, B. | +15

10

Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Nguyen, J. | Takebe, N. | Kummar, S. | +15

CommentIn: Clin Cancer Res. 2023 Apr 3;29(7):1163-1166. - PMID 36692840

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[26]